Adolor: Is There Anything Left?
Adolor Corp. (ADLR-NASDAQ) may have just joined the ranks of current and future biotech zombies. The company suspended its lead new drug candidate for potential treatment of opioid-induced bowel dysfunction. Safety concerns prompted the…